Alternatives – Page 20
-
White papers
The Circular, Edition 2, 2021
The Circular cuts to the heart of the issues that matter in the second ESG quarterly update for 2021..
-
White papers
Carbon Credits: Seeing the wood for the trees
As governments and companies strive to reduce carbon emissions and achieve net zero, questions are being asked about the role of natural climate solutions. We analyse differing approaches to offsetting and their impact on forest management.
-
White papers
Measuring and Pricing Cyclone-Related Physical Risk under Changing Climate
We propose a statistical methodology to quantify the financial implications of tropical cyclone-related physical risks implied by climate change.
-
White papers
The Case For Central Bank Action On Climate Change—An Evolution To Facilitate A Revolution
The traditional view of central banks’ role no longer appears to align with government objectives and the public’s growing desire to address climate change.
-
White papers
Medical miracle: Health care innovation saves the world
Several drug developers brought COVID-19 vaccines from initial trials to people’s arms in less than a year. This lightning quick pace defied the expectations of health care professionals and saved countless lives. It was far faster than the development of any similar drug.
-
White papers
From Diets to Tech: The Opportunity in Sustainable Agriculture
A technological revolution is reshaping the agricultural landscape, creating opportunities in companies that are increasing the sustainability of arable farming and protein production.
-
White papers
Powering progress: the Sycomore Global Education Fund
Education is the engine of human progress. The fund managers talk about the main opportunities they see in this underappreciated sector and the strategies they’re adopting to generate value while advancing this key lever in the battle to improve global equality.
-
White papers
By the people, for the people: Why investors should care about human rights
Companies cannot thrive without healthy and happy employees, consumers, and communities. Investors must use their influence with companies and other stakeholders to ensure the basic rights of these groups are respected.
-
White papers
* Our roadmap to addressing biodiversity loss *
Biodiversity loss entails physical, transition and systemic risks for investors. That is why BNP Paribas Asset Management believes it is essential to integrate biodiversity into its approach to sustainable investing including reporting on its water and forest footprints and developing common biodiversity metrics.
-
White papers
How to talk to clients about Bitcoin
Fear of missing out is a powerful force in investing. And it’s difficult to ignore an asset that has gained more than 500,000% in just a few years, eliciting headline-grabbing commentary from Elon Musk and Warren Buffett, among others.
-
White papers
Plant-based food and alternative proteins look set to upend food industry
The food industry is on the brink of a decade of profound change. Unparalleled growth in plant, micro-organism, and animal-cell based alternatives has the potential to drive this change as consumer tastes evolve, meat intake is being reduced or cut altogether and demand for alternative food types rises.
-
White papers
Responsible investing at Nuveen
Unlocking investment potential while making an enduring impact on our world
-
White papers
COVID, capital and climate: An interview with Ashish Dafria
Ashish Dafria, chief investment officer for Aviva, discusses the investment implications of the pandemic, climate change and the macroeconomic environment for a large insurer.
-
White papers
* Sustainability in the time of uncertainty *
Here is the third in a series of regular articles on current academic research into a range of responsible investment topics. The papers discussed were presented at the annual GRASFI [1] conference.
-
White papers
Sustainable investing – Our approach to stewardship
As part of our stewardship strategy, we regard proxy voting as a key component of being a responsible and transparent investor.
-
White papers
Geopolitics of the vaccine
Eighteen months after the first Covid-19 cases hit China, the outbreak is still uncontrolled globally and remains the main source of economic uncertainty outside Northern Asia. As long as there is no treatment, access to effective vaccines is the main factor in returning to a ‘normal’ life.
-
White papers
* For long-term profitability, inclusive growth matters *
Companies focused on inclusive growth could stand to benefit in the long run. Investment specialist Ramon Esteruelas and environmental, social and governance (ESG) research analyst Delphine Riou explain why and how investors can target this theme.
-
White papers
Insurance Summit: Partnering for Positive Change
Climate protection and opportunities: how to integrate holistically across insurance portfolios